Compounds > 2-(n,n-dipropyl)amino-6,7-dihydroxytetralin
Page last updated: 2024-09-03

2-(n,n-dipropyl)amino-6,7-dihydroxytetralin and des-enkephalin-gamma-endorphin

2-(n,n-dipropyl)amino-6,7-dihydroxytetralin has been researched along with des-enkephalin-gamma-endorphin in 1 studies

Compound Research Comparison

Studies
(2-(n,n-dipropyl)amino-6,7-dihydroxytetralin)		Trials
(2-(n,n-dipropyl)amino-6,7-dihydroxytetralin)		Recent Studies (post-2010)
(2-(n,n-dipropyl)amino-6,7-dihydroxytetralin)		Studies
(des-enkephalin-gamma-endorphin)		Trials
(des-enkephalin-gamma-endorphin)		Recent Studies (post-2010) (des-enkephalin-gamma-endorphin)
11004160

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horn, AS; Radhakishun, FS; Van Ree, JM1

Other Studies

1 other study(ies) available for 2-(n,n-dipropyl)amino-6,7-dihydroxytetralin and des-enkephalin-gamma-endorphin

ArticleYear
Desenkephalin-gamma-endorphin and neuroleptics counteract the DP-7-ATN-induced hypomotility after intra-accumbens treatment.
    European journal of pharmacology, 1988, Feb-16, Volume: 147, Issue:1

    Topics: Animals; Antipsychotic Agents; beta-Endorphin; Haloperidol; Injections; Male; Motor Activity; Naphthalenes; Nucleus Accumbens; Rats; Rats, Inbred Strains; Sulpiride; Tetrahydronaphthalenes

1988